Tardive Dyskinesia, Tardive Dystonia, and Tardive Tourette's Syndrome in Children and Adolescents

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

This article summarizes the current clinical literature on adverse nonparkinsonian motor side effects of neuroleptic use in children and adolescents. The research diagnoses for Tardive Dyskinesia by Schooler and Kane (1982) served as a framework for comparing the early literature to more recent studies of various forms of tardive dyskinesia. Patient demographics, medication-related variables, symptom duration, topography, and prevalence were reviewed. Neuroleptic-associated tardive dystonia and tardive Gilles de la Tourette's syndrome are also considered. Prevalence rates of tardive dyskinesia during neuroleptic treatment typically range from a mean of 1 to 4.8% (compared to about 20% in adults), and the mean rate for withdrawal tardive dyskinesia is approximately 22% (compared to 34% in adults). There are no documented cases of permanent tardive dyskinesia, but tardive dyskinesia in youth has been reported in some cases to last up to 4.5 years. Further systematic investigation is necessary to clearly identify risk factors associated with these disorders, which at present appear to be similar to risk factors for tardive dykinesia in adults.

Original languageEnglish (US)
Pages (from-to)175-198
Number of pages24
JournalJournal of Child and Adolescent Psychopharmacology
Volume3
Issue number4
DOIs
StatePublished - 1993

Fingerprint

Tourette Syndrome
Antipsychotic Agents
Tardive Dyskinesia
Demography
Research

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

@article{795c81d50d884ef7b1ff7e5e7ac1c6d7,
title = "Tardive Dyskinesia, Tardive Dystonia, and Tardive Tourette's Syndrome in Children and Adolescents",
abstract = "This article summarizes the current clinical literature on adverse nonparkinsonian motor side effects of neuroleptic use in children and adolescents. The research diagnoses for Tardive Dyskinesia by Schooler and Kane (1982) served as a framework for comparing the early literature to more recent studies of various forms of tardive dyskinesia. Patient demographics, medication-related variables, symptom duration, topography, and prevalence were reviewed. Neuroleptic-associated tardive dystonia and tardive Gilles de la Tourette's syndrome are also considered. Prevalence rates of tardive dyskinesia during neuroleptic treatment typically range from a mean of 1 to 4.8{\%} (compared to about 20{\%} in adults), and the mean rate for withdrawal tardive dyskinesia is approximately 22{\%} (compared to 34{\%} in adults). There are no documented cases of permanent tardive dyskinesia, but tardive dyskinesia in youth has been reported in some cases to last up to 4.5 years. Further systematic investigation is necessary to clearly identify risk factors associated with these disorders, which at present appear to be similar to risk factors for tardive dykinesia in adults.",
author = "Dwight Wolf and Karen Wagner",
year = "1993",
doi = "10.1089/cap.1993.3.175",
language = "English (US)",
volume = "3",
pages = "175--198",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Tardive Dyskinesia, Tardive Dystonia, and Tardive Tourette's Syndrome in Children and Adolescents

AU - Wolf, Dwight

AU - Wagner, Karen

PY - 1993

Y1 - 1993

N2 - This article summarizes the current clinical literature on adverse nonparkinsonian motor side effects of neuroleptic use in children and adolescents. The research diagnoses for Tardive Dyskinesia by Schooler and Kane (1982) served as a framework for comparing the early literature to more recent studies of various forms of tardive dyskinesia. Patient demographics, medication-related variables, symptom duration, topography, and prevalence were reviewed. Neuroleptic-associated tardive dystonia and tardive Gilles de la Tourette's syndrome are also considered. Prevalence rates of tardive dyskinesia during neuroleptic treatment typically range from a mean of 1 to 4.8% (compared to about 20% in adults), and the mean rate for withdrawal tardive dyskinesia is approximately 22% (compared to 34% in adults). There are no documented cases of permanent tardive dyskinesia, but tardive dyskinesia in youth has been reported in some cases to last up to 4.5 years. Further systematic investigation is necessary to clearly identify risk factors associated with these disorders, which at present appear to be similar to risk factors for tardive dykinesia in adults.

AB - This article summarizes the current clinical literature on adverse nonparkinsonian motor side effects of neuroleptic use in children and adolescents. The research diagnoses for Tardive Dyskinesia by Schooler and Kane (1982) served as a framework for comparing the early literature to more recent studies of various forms of tardive dyskinesia. Patient demographics, medication-related variables, symptom duration, topography, and prevalence were reviewed. Neuroleptic-associated tardive dystonia and tardive Gilles de la Tourette's syndrome are also considered. Prevalence rates of tardive dyskinesia during neuroleptic treatment typically range from a mean of 1 to 4.8% (compared to about 20% in adults), and the mean rate for withdrawal tardive dyskinesia is approximately 22% (compared to 34% in adults). There are no documented cases of permanent tardive dyskinesia, but tardive dyskinesia in youth has been reported in some cases to last up to 4.5 years. Further systematic investigation is necessary to clearly identify risk factors associated with these disorders, which at present appear to be similar to risk factors for tardive dykinesia in adults.

UR - http://www.scopus.com/inward/record.url?scp=85012553158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012553158&partnerID=8YFLogxK

U2 - 10.1089/cap.1993.3.175

DO - 10.1089/cap.1993.3.175

M3 - Article

VL - 3

SP - 175

EP - 198

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 4

ER -